Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00556218 · ClinicalTrials.gov registry record · NA
Meditation and Cognitive Function in Women With Breast Cancer
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT00556218: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT00556218 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00556218, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
The goal of this behavioral research study is to learn if participating in a Tibetan meditation program helps to improve quality of life for women after chemotherapy and during recovery from breast cancer. Whether the meditation program helps to improve brain function and sleep quality will also be studied.
Interventions
- BEHAVIORAL Tibetan Meditation Program
- BEHAVIORAL No Meditation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2007-10-24 |
| Est. Completion | 2022-08-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00556218
The ClinicalTrials.gov registry entry for NCT00556218 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tibetan Meditation Program is the first listed.
NCT00556218 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00556218 about?
NCT00556218 is a clinical study titled "Meditation and Cognitive Function in Women With Breast Cancer". The goal of this behavioral research study is to learn if participating in a Tibetan meditation program helps to improve quality of life for women after chemotherapy and during recovery from breast cancer. Whether the meditation program helps to improve brain function and sleep quality will also be ...
What is the current status of trial NCT00556218?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2007-10-24. Estimated completion is 2022-08-10.
What interventions are being tested in trial NCT00556218?
The interventions under investigation include: Tibetan Meditation Program (BEHAVIORAL), No Meditation (BEHAVIORAL).
Who is sponsoring clinical trial NCT00556218?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.